Income Statement

UNITED THERAPEUTICS CORP

UTHR
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY Dec 31, 2010 2010 FY
Revenue
3,182.70 2,877.40 2,327.50 1,936.30 1,685.50 1,483.30 1,448.80 1,627.80 1,725.30 1,598.80 1,465.76 1,288.52 1,116.98 916.08 743.18 603.83
Cost of Revenue
384.40 309.70 257.50 151.60 122.50 108.10 117.60 198.70 - - - - - - - -
Gross Profit
-24,883.10 -22,454.50 -17,988.40 -9,227.70 -9,745.50 1,375.20 1,331.20 1,429.10 1,725.30 1,598.80 1,465.76 -2,307.30 -1,951.63 916.08 743.18 603.83
Operating Expenses
1,305.80 1,190.70 885.10 322.90 540.10 357.70 1,182.60 623.70 594.70 464.40 697.71 623.84 693.36 375.13 336.50 366.36
Research & Development
550.00 481.00 408.00 322.90 540.10 357.70 1,182.60 357.90 264.60 147.60 245.10 242.55 299.35 173.39 180.02 166.76
Selling, General & Administrative
755.80 709.70 477.10 - - - - 265.80 330.10 316.80 452.61 381.29 394.01 201.75 156.48 199.60
Other Operating Expenses
- - - - - - - - - - - - - - - -
Operating Income
1,492.50 1,377.00 1,184.90 1,461.80 1,022.90 1,017.50 148.60 805.40 1,130.60 1,134.40 768.05 664.68 423.63 540.94 406.69 237.47
Non-Operating Income
221.40 162.00 89.40 -29.10 38.00 45.30 22.60 -46.50 -45.40 -1.50 345.42 -13.62 -13.60 19.03 -18.67 -16.17
Interest Income
192.00 199.10 162.70 45.20 16.70 28.60 44.20 28.60 - - - - 3.83 3.94 3.45 2.94
Interest Expense
- - 59.30 32.40 18.60 23.50 44.20 13.90 9.00 3.90 4.74 17.59 18.06 16.64 22.21 19.71
Other Non-Op Income / Expense
48.90 5.80 -14.00 -40.20 42.20 49.30 22.60 -7.70 13.20 2.40 0.16 3.97 0.64 -0.14 -0.12 -0.16
Income Before Tax
1,713.90 1,539.00 1,274.30 950.60 593.90 638.90 -165.00 758.90 769.50 1,060.20 1,044.44 525.18 278.90 440.67 299.12 -
Income Tax Expense
379.20 343.90 289.50 223.30 118.10 124.10 -60.50 169.70 351.60 346.50 392.80 185.11 104.34 136.23 81.87 41.92
Non-Controlling Interest
- - - - - - - - - - - - - - - -
Net Income
1,334.70 1,195.10 984.80 - - - - - - - - - - - - 105.92
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY Dec 31, 2010 2010 FY
Depreciation & Amortization
- - - - - - - - - - - - - - - -
EBITDA
1,578.10 1,449.50 1,238.10 1,513.10 1,072.80 1,067.40 194.50 841.30 1,161.60 1,166.00 800.97 696.93 454.89 568.09 427.22 255.39
Earnings Per Share (Basic)
30.13 26.44 21.04 15.98 10.60 11.65 -2.39 13.54 9.50 16.29 14.17 7.06 3.49 5.84 3.81 1.89
Diluted EPS
27.86 24.64 19.81 15.00 10.06 11.54 -2.39 13.39 9.31 15.25 12.72 6.28 3.28 5.71 3.67 1.78
Weighted Average Shares
44.30 45.20 46.80 45.50 44.90 44.20 43.80 43.50 44.00 43.80 46.00 48.18 50.08 52.09 57.16 56.14
Diluted Weighted Avg Shares
47.90 48.50 49.70 48.50 47.30 44.60 43.80 44.00 44.90 46.80 51.22 54.16 53.23 53.28 59.40 59.52
Comprehensive Income
1,339.00 1,204.50 1,027.50 694.80 467.00 514.80 -110.80 600.90 415.10 717.30 647.97 336.52 176.33 300.37 217.87 -